Heron Therapeutics, Inc. · NASDAQ:HRTX

Forbes William P exercised options for 23,463 Heron Therapeutics, Inc. shares (Form 4)

Traded Jul 30 to Jul 31, 2026 · Filed Aug 3, 2026

From Jul 30 to Jul 31, 2026, Forbes William P (EVP, Chief Development Officer) exercised options for 23,463 Heron Therapeutics, Inc. shares, leaving 241,173 shares. Filed Aug 3, 2026 (Form 4).

Options exercised
23,463 shares
Holding after
241,173 shares
Trading plan
No
Role
EVP, Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 30, 2026Common StockOption exercise11,769236,153Direct
Jul 30, 2026Common StockShares withheld for tax3,348US$0.50232,805Direct
Jul 31, 2026Common StockOption exercise11,694244,499Direct
Jul 31, 2026Common StockShares withheld for tax3,326US$0.50241,173Direct

Source

View original at SEC

Related